The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis
Open accessAbstract
Recent research suggests that SARS-CoV-2-infected individuals can be highly infectious while asymptomatic or pre-symptomatic, and that an infected person may infect 5.6 other individuals on average. This situation highlights the need for rapid, sensitive SARS-CoV-2 diagnostic assays capable of high-throughput operation that can preferably utilize existing equipment to facilitate broad, large-scale screening efforts. We have developed a CRISPR-based assay that can meet all these criteria. This assay utilizes a custom CRISPR Cas12a/gRNA complex and a fluorescent probe to detect target amplicons produced by standard RT-PCR or isothermal recombinase polymerase amplification (RPA), to allow sensitive detection at sites not equipped with real-time PCR systems required for qPCR diagnostics. We found this approach allowed sensitive and robust detection of SARS-CoV-2 positive samples, with a sample-to-answer time of ~50 min, and a limit of detection of 2 copies per sample. CRISPR assay diagnostic results obtained nasal swab samples of individuals with suspected COVID-19 cases were comparable to paired results from a CDC-approved quantitative RT-PCR (RT-qPCR) assay performed in a state testing lab, and superior to those produced by same assay in a clinical lab, where the RT-qPCR assay exhibited multiple invalid or inconclusive results. Our assay also demonstrated greater analytical sensitivity and more robust diagnostic performance than other recently reported CRISPR-based assays. Based on these findings, we believe that a CRISPR-based fluorescent application has potential to improve current COVID-19 screening efforts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Self-citationA pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
Self-citationLoop-mediated isothermal amplification of DNA
Notomi, T. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.12.e63 · Cited by 8,805
Ai, T., Yang, Z., Hou, H., Zhan, C., Chen, C., Lv, W., Tao, Q., Sun, Z., & Xia, L. (2020) · Radiology · doi:10.1148/radiol.2020200642 · Cited by 5,685
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
Zou, L., Ruan, F., Huang, M., Liang, L., Huang, H., Hong, Z., Yu, J., Kang, M., Song, Y., Xia, J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001737 · Cited by 4,810
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Chen, J. S., Ma, E., Harrington, L. B., Da Costa, M., Tian, X., Palefsky, J. M., & Doudna, J. A. (2018) · Science · doi:10.1126/science.aar6245 · Cited by 4,507
Nucleic acid detection with CRISPR-Cas13a/C2c2
Gootenberg, J. S., Abudayyeh, O. O., Lee, J. W., Essletzbichler, P., Dy, A. J., Joung, J., Verdine, V., Donghia, N., Daringer, N. M., Freije, C. A., et al. (2017) · Science · doi:10.1126/science.aam9321 · Cited by 3,844
The reproductive number of COVID-19 is higher compared to SARS coronavirus
Liu, Y., Gayle, A. A., Wilder-Smith, A., & Rocklöv, J. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa021 · Cited by 3,192
Self-citationCRISPR–Cas12-based detection of SARS-CoV-2
Broughton, J. P., Deng, X., Yu, G., Fasching, C. L., Servellita, V., Singh, J., Miao, X., Streithorst, J. A., Granados, A., Sotomayor-Gonzalez, A., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0513-4 · Cited by 2,717
Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6
Gootenberg, J. S., Abudayyeh, O. O., Kellner, M. J., Joung, J., Collins, J. J., & Zhang, F. (2018) · Science · doi:10.1126/science.aaq0179 · Cited by 2,638
Mizumoto, K., Kagaya, K., Zarebski, A., & Chowell, G. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.10.2000180 · Cited by 2,276
Real-Time PCR for mRNA Quantitation
Wong, M. L., & Medrano, J. F. (2005) · BioTechniques · doi:10.2144/05391rv01 · Cited by 1,786
Diagnosing COVID-19: The Disease and Tools for Detection
Udugama, B., Kadhiresan, P., Kozlowski, H. N., Malekjahani, A., Osborne, M., Li, V. Y. C., Chen, H., Mubareka, S., Gubbay, J. B., & Chan, W. C. W. (2020) · ACS Nano · doi:10.1021/acsnano.0c02624 · Cited by 1,754
High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2
Sanche, S., Lin, Y. T., Xu, C., Romero-Severson, E., Hengartner, N., & Ke, R. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200282 · Cited by 1,619
CRISPR-Cas12a-assisted nucleic acid detection
Li, S.-Y., Cheng, Q.-X., Wang, J.-M., Li, X.-Y., Zhang, Z.-L., Gao, S., Cao, R.-B., Zhao, G.-P., & Wang, J. (2018) · Cell Discovery · doi:10.1038/s41421-018-0028-z · Cited by 1,530
Rapid, Low-Cost Detection of Zika Virus Using Programmable Biomolecular Components
Pardee, K., Green, A. A., Takahashi, M. K., Braff, D., Lambert, G., Lee, J. W., Ferrante, T., Ma, D., Donghia, N., Fan, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.059 · Cited by 1,439
Ultrasensitive and visual detection of SARS-CoV-2 using all-in-one dual CRISPR-Cas12a assay
Ding, X., Yin, K., Li, Z., Lalla, R. V., Ballesteros, E., Sfeir, M. M., & Liu, C. (2020) · Nature Communications · doi:10.1038/s41467-020-18575-6 · Cited by 919
CRISPR/Cas Systems towards Next-Generation Biosensing
Li, Y., Li, S., Wang, J., & Liu, G. (2019) · Trends in Biotechnology · doi:10.1016/j.tibtech.2018.12.005 · Cited by 917
Isothermal nucleic acid amplification technologies for point-of-care diagnostics: a critical review
Craw, P., & Balachandran, W. (2012) · Lab on a Chip · doi:10.1039/c2lc40100b · Cited by 766
Hajian, R., Balderston, S., Tran, T., deBoer, T., Etienne, J., Sandhu, M., Wauford, N. A., Chung, J.-Y., Nokes, J., Athaiya, M., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0371-x · Cited by 646
Isothermal reactions for the amplification of oligonucleotides
Van Ness, J., Van Ness, L. K., & Galas, D. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730811100 · Cited by 542
Yu, L., Wu, S., Hao, X., Dong, X., Mao, L., Pelechano, V., Chen, W.-H., & Yin, X. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa102 · Cited by 477
Self-citationBruch, R., Baaske, J., Chatelle, C., Meirich, M., Madlener, S., Weber, W., Dincer, C., & Urban, G. A. (2019) · Advanced Materials · doi:10.1002/adma.201905311 · Cited by 449
Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP
Zhang, Y., Odiwuor, N., Xiong, J., Sun, L., Nyaruaba, R. O., Wei, H., & Tanner, N. A. (2020) · medRxiv · doi:10.1101/2020.02.26.20028373 · Cited by 355
Smithgall, M. C., Scherberkova, I., Whittier, S., & Green, D. A. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104428 · Cited by 192
Communicating the Risk of Death from Novel Coronavirus Disease (COVID-19)
Kobayashi, T., Jung, S.-M., Linton, N. M., Kinoshita, R., Hayashi, K., Miyama, T., Anzai, A., Yang, Y., Yuan, B., Akhmetzhanov, A. R., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020580 · Cited by 181
Harrington, A., Cox, B., Snowdon, J., Bakst, J., Ley, E., Grajales, P., Maggiore, J., & Kahn, S. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00798-20 · Cited by 162
Curti, L. A., Pereyra-Bonnet, F., & Giménez, C. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.29.971127 · Cited by 150
Reverse-Transcription PCR (RT-PCR)
Bachman, J. L. (2013) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-420037-1.00002-6 · Cited by 135
Recombinase polymerase amplification as a promising tool in hepatitis C virus diagnosis
Zaghloul, H., & El-Shahat, M. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i12.916 · Cited by 107
CRISPR/Cas Powered Multiplexed Biosensing
Bruch, R. C., Urban, G. A., & Dincer, C. (2019) · Trends in biotechnology · doi:10.1016/j.tibtech.2019.04.005 · Cited by 97
Homogeneous Entropy-Driven Amplified Detection of Biomolecular Interactions
Kim, D., Garner, O. B., Özcan, A., & Carlo, D. D. (2016) · ACS Nano · doi:10.1021/acsnano.6b02060 · Cited by 70
The Hazards of Passive -- And Active -- Smoking
Boyle, P. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306103282311 · Cited by 47
Cited by
Diagnostics for SARS-CoV-2 infections
Kevadiya, B. D., Machhi, J., Herskovitz, J., Oleynikov, M. D., Blomberg, W. R., Bajwa, N., Soni, D., Das, S., Hasan, M., Patel, M., et al. (2021) · Nature Materials · doi:10.1038/s41563-020-00906-z · Cited by 833
Considerations for diagnostic COVID-19 tests
Vandenberg, O., Martiny, D., Rochas, O., van Belkum, A., & Kozlakidis, Z. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00461-z · Cited by 803
Chen, Z., Li, J., Li, T., Fan, T., Meng, C., Li, C., Kang, J., Chai, L., Hao, Y., Tang, Y., et al. (2022) · National Science Review · doi:10.1093/nsr/nwac104 · Cited by 557
Torrente-Rodríguez, R. M., Lukas, H., Tu, J., Min, J., Yang, Y., Xu, C., Rossiter, H. B., & Gao, W. (2020) · Matter · doi:10.1016/j.matt.2020.09.027 · Cited by 490
Fabiani, L., Saroglia, M., Galatà, G., De Santis, R., Fillo, S., Luca, V., Faggioni, G., D'Amore, N., Regalbuto, E., Salvatori, P., et al. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112686 · Cited by 434
Metadata
- Authors
- Huang, Z., Tian, D., Liu, Y., Lin, Z., Lyon, C. J., Lai, W., Fusco, D., Drouin, A., Yin, X., Hu, T., & Ning, B.
- Venue
- Biosensors and Bioelectronics
- Publisher
- Elsevier BV
- Published
- 2020-09
- Volume
- 164
- Pages
- 112316
- ISSN
- 0956-5663 (ISSN-L)
- OpenAlex
- W3026715285
- Cited by
- 332
- References
- 34
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.